$MBRX
Moleculin Biotech, Inc.
XNAS•Health Care•Pharmaceutical Preparations
$0.550
▲+4.19%+$0.022
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMoleculin Biotech, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is MBRX up today? It is at $0.550 (+4.19%), and our scanner flagged it 31 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MBRX spikes, and full due diligence on MBRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $MBRX 31 times in the last 30 days. Create a free account to track $MBRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on MBRX from our scanner (live price and day move above). Fresh from the SEC: Moleculin Biotech Secures Mexican Patent Protecting Lung-Targeted Liposomal Annamycin Through 2040. A material company disclosure like this is often the real catalyst behind a move of this size.
Latest filing8-KRegulation FD Disclosure, Other Material EventSep 23, 2026 · yesterday| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Picker Donald H Officer | Acquired (grant/award) | +173K 0.9% of company | added 100% | 174K | n/a | Aug 3, 26 |
Klemp Walter V Officer | Acquired (grant/award) | +533K 2.7% of company | added 100% | 564K | n/a | Aug 3, 26 |
Foster Jonathan P. Officer | Acquired (grant/award) | +293K 1.5% of company | added 100% | 306K | n/a | Aug 3, 26 |
Foster Jonathan P. Officer | Sold (automatic/other) | -41 | sold 0.3% | 12K | $128 at $3.12 | Jun 22, 26 |
Foster Jonathan P. Officer | Other | 174 | added 1.4% | 12K | n/a | Jun 22, 26 |
Klemp Walter V Officer | Sold (automatic/other) | -88 | sold 0.3% | 31K | $275 at $3.12 | Jun 22, 26 |
Klemp Walter V Officer | Other | 360 | added 1.2% | 31K | n/a | Jun 22, 26 |
Picker Donald H Officer | Sold (automatic/other) | -21 | sold 2.7% | 753 | $66 at $3.12 | Jun 22, 26 |
Picker Donald H Officer | Other | 71 | added 10% | 774 | n/a | Jun 22, 26 |
Foster Jonathan P. Officer | Sold (automatic/other) | -31 | sold 0.3% | 12K | $89 at $2.88 | Jun 20, 26 |
Foster Jonathan P. Officer | Other | 109 | added 0.9% | 12K | n/a | Jun 20, 26 |
Klemp Walter V Officer | Sold (automatic/other) | -37 | sold 0.1% | 31K | $107 at $2.88 | Jun 20, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on MBRX from our scanner (live price and day move above). Fresh from the SEC: Moleculin Biotech Secures Mexican Patent Protecting Lung-Targeted Liposomal Annamycin Through 2040. A material company disclosure like this is often the real catalyst behind a move of this size.
MBRX last traded at $0.550, up 4.19% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Moleculin Biotech, Inc. (MBRX) is next expected to report earnings on Thursday, November 12, 2026, about 49 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The MBRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MBRX 31 times in the last 30 days.
MBRX (Moleculin Biotech, Inc.) trades on XNAS, with a market cap of about $11M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MBRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MBRX discussion
Sign in to ask a question or join the discussion.